Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies.
about
Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogsAn open-label phase 1 dose-escalation clinical trial of a single intravenous administration of gemcitabine in dogs with advanced solid tumors.Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.Fixed-dose-rate administration of gemcitabine in cancer-bearing cats: A pilot study.Single agent gemcitabine chemotherapy in dogs with spontaneously occurring lymphoma.
P2860
Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies.
@en
Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies.
@nl
type
label
Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies.
@en
Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies.
@nl
prefLabel
Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies.
@en
Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies.
@nl
P2093
P1476
Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies.
@en
P2093
C Guillermo Couto
Carrie E Kosarek
Stacey L Gallant
William C Kisseberth
P356
10.1111/J.1939-1676.2005.TB02662.X
P577
2005-01-01T00:00:00Z